Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Hydrochlorothiazide; Irbesartan Patent Expiration

Hydrochlorothiazide; Irbesartan was first introduced by Sanofi Aventis Us Llc in its drug Avalide on Sep 30, 1997. 16 different companies have introduced drugs containing Hydrochlorothiazide; Irbesartan.


Hydrochlorothiazide; Irbesartan Patents

Given below is the list of patents protecting Hydrochlorothiazide; Irbesartan, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

Country : United States (US)
Patent Category : All
Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Avalide US5994348

(Pediatric)

 Pharmaceutical compositions containing irbesartan Dec 07, 2015

(Expired)

 Sanofi Aventis Us
Avalide US5994348 Pharmaceutical compositions containing irbesartan Jun 07, 2015

(Expired)

 Sanofi Aventis Us



Hydrochlorothiazide; Irbesartan's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Hydrochlorothiazide; Irbesartan Generic API Manufacturers

Several generic applications have been filed for Hydrochlorothiazide; Irbesartan. The first generic version for Hydrochlorothiazide; Irbesartan was by Teva Pharmaceuticals Usa Inc and was approved on Mar 30, 2012. And the latest generic version is by Unichem Laboratories Ltd and was approved on Sep 19, 2017.

Given below is the list of companies who have filed for Hydrochlorothiazide; Irbesartan generic, along with the locations of their manufacturing plants worldwide.